- Home
- ASTH vs UROY Comparison
ASTH vs UROY Comparison
Compare ASTH & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASTH | UROY |
|---|---|---|
| Founded | 1994 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2015 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ASTH | UROY |
|---|---|---|
| Price | $37.94 | $4.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $34.86 | N/A |
| AVG Volume (30 Days) | 447.2K | ★ 2.6M |
| Earning Date | 05-07-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $519,907,752.00 | N/A |
| Revenue This Year | $27.38 | $279.20 |
| Revenue Next Year | $10.78 | N/A |
| P/E Ratio | ★ $55.67 | $1,584.46 |
| Revenue Growth | ★ 45.90 | N/A |
| 52 Week Low | $18.08 | $2.56 |
| 52 Week High | $51.60 | $5.52 |
Technical Indicators
Market Signals| Indicator | ASTH | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 47.77 | 62.75 |
| Support Level | $36.47 | $3.54 |
| Resistance Level | $40.35 | $4.48 |
| Average True Range (ATR) | 1.91 | 0.20 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 59.71 | 54.31 |
Price Performance
Historical ComparisonAbout ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.